LLC (WCC), a leading imaging CRO focused on maximizing the precision

and accuracy of independent assessments in clinical trials, today

introduced a new service offering that supports expert readers in a

timely and transparent manner to complete cardiovascular endpoint

committee reviews quickly and cost-effectively.

In response to FDA guidance and growing requests from other regulatory

agencies that place new emphasis on assessing and minimizing

cardiovascular risk, WCC has developed a comprehensive and easy-to-use

solution for cost-effective, Blinded Independent Central Review (BICR)

of adverse events (AEs) using the Medical Dictionary for Regulatory

Activities (MedDRA) and other safety coding dictionaries. WCC's new

service offering builds upon the company's extensive Endpoint

Assessment Committee (EAC)


and employs its


image management platform to capture, quantify and consolidate

virtually any type of clinical data for interpretation by

sub-specialty trained experts.

"We're excited to introduce the first of several new services we'll be

offering to sponsors in the coming months," said Richard Walovitch,

PhD, president of WorldCare Clinical, LLC. "Through our long-standing

strategic relationship with Massachusetts General Hospital (MGH),

we're able to deliver the most accurate assessments by providing

access to leading clinical experts to meet each trial's specific

protocol requirements. This combined with our proprietary digital

portal, WorldPRO, provides the ability to streamline the BICR process

and highlights the flexibility of our capabilities."

WCC's new service offering for cardiovascular endpoint committees

consists of the following:

The WorldPRO system can be accessed by multiple clinical scientists at

different locations to collate potential Events of Interest (EoIs) for

internal or external review. Equipped with a smart work queue and

automated adjudication workflow, WorldPRO allows clinicians to review

data efficiently to further expedite the review process. Additionally,

WCC has included a standardized scoring system to assess the degree of

certainty of the EoI. This unique feature enables WCC to better

determine variance in AE coding between independent reviews, while

maintaining training and testing programs that maximize the precision

and accuracy of a clinical trial.

For more information about WCC's new service offering, visit:

About WorldCare ClinicalWorldCare Clinical (WCC) is a leading imaging

CRO that employs imaging expertise, innovative technology and

operational excellence to maximize the precision and accuracy of a

blinded independent central review of clinical trial data. Originally

founded in 1992 by the Massachusetts General Hospital (MGH) Department

of Radiology, WCC has evolved as an independent company while

maintaining a strategic relationship with MGH. With a 20-year focus on

imaging trials and their specific requirements, WCC provides sponsors

with extensive medical, operational, and image management expertise in

support of even the most complex study designs. For more information,


Add to